Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment that uses targeted magnetic pulses to stimulate areas of the brain involved in mood regulation. TMS is FDA-approved and commonly used for depression, anxiety, OCD, and treatment-resistant conditions.

Modern neuroscience has shown that mental health conditions involve measurable changes in brain function and neural communication. Neuromodulation offers a more targeted way to address these changes by acting directly on specific brain networks.

Medications affect the entire body through the bloodstream, while TMS targets specific brain regions involved in mood regulation. This allows treatment to be more localized and avoids many systemic side effects associated with medications.

Psychotherapy can create meaningful changes in brain function over time. TMS aims to influence similar neural pathways directly through targeted brain stimulation, potentially producing changes more quickly.

BDNF (Brain-Derived Neurotrophic Factor) is a naturally occurring protein that supports the growth, survival, and adaptation of brain cells. It plays an important role in neuroplasticity—the brain’s ability to change and adapt.

BDNF helps neurons grow, form connections, and function more effectively. For this reason, it is often described as “fertilizer for the brain.”

Research suggests that TMS may increase BDNF activity, helping support healthy brain function and neuroplasticity.